Reasons for this are thought to include less one-on-one time with parents, the premature birth of twins, and the companionship of their twin sibling reducing their motivation to talk to others. A twin study has also shown that genetic factors have an important role in language delay. Monozygotic twin pairs (identical twins) recorded a higher consistency than dizygotic twin (fraternal twins) pairs, revealing monozygotic twins experiencing early vocabulary delay is attributed to genetic etiology. The environmental factors that influences both twins also play a big role in causing early language delay, but only when it is transient.Gender
Research has shown that boys are at greater risk for delayed language development than girls. Almost all developmental disorders that affect communication, speech and language skills are more common in males than in females. British scientists have found that the male sex hormone (testosterone) levels were related to the development of both autism and language disorders, which explains why boys are at a greater risk of developmental disorders biologically.Perinatal conditions
There is a high prevalence of early language delay among toddlers with neonatal brachial plexus palsy. Hand usage and gestures are part of the motor system and have been proven correlate to comprehension and production aspects in language development. An interruption in the hand/arm usage caused by this condition during stages of language development could possibly cause these children to experience language delays.Stress during pregnancy is associated with language delay. High levels of prenatal stress can result in poorer general intellectual and language outcomes.
In Germany, paxlovid is by prescription through physicians only and German physicians have been reluctant to prescribe it. Hence health minister Karl Lauterbach decided that general practitioners can stock 5 Paxlovid courses in their practice and dispense it directly to patients, that a prescription would be remunerated with 15 euros and that every nursing home should appoint a vaccination officer as well as a Paxlovid officer. As of August 2022 the treatment guidelines, which German family doctors follow, have not been updated since February 2022 and recommend Paxlovid only in unvaccinated risk patients, i.e. in only a few people.As of April 2022, the United States ordered a total of 20 million Paxlovid courses. As of July 2022, the United States Department of Health and Human Services set up at least 2,200 sites where people could receive Paxlovid as soon as they test positive for the virus, including pharmacies, community health centers and long-term care facilities. In July 2022, the US FDA allowed state-licensed pharmacists to prescribe it to people with COVID-19 at high risk of progressing to severe disease. Comparison to ivermectin
The co-packaged medication is sometimes falsely claimed to be a repackaged version of the antiparasitic drug ivermectin, which has been promoted as a COVID-19 therapeutic. Such claims, sometimes using the nickname "Pfizermectin", rely on superficial similarities between the mechanism of action of both drugs and the claim that Pfizer is suppressing the benefits of ivermectin. References
External links
Halford B (January 2022). "How Pfizer scientists transformed an old drug lead into a COVID-19 antiviral".